Orvepitant Maleate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Nerre Therapeutics Ltd.
Overview
Orvepitant Maleate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Orvepitant Maleate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Orvepitant Maleate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.